Algonomics to work with IAVI on new approach to AIDS vaccine

The privately-owned Belgian biotechnology company, Algonomics, has signed an agreement with the International AIDS Vaccine Initiative (IAVI) to investigate a new approach to improve the immunogenicity of candidate AIDS vaccines.